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Abstract 
We describe here a case of pure gastric yolk
sac tumor (YST). A 62-year-old patient under-
went gastrectomy with D2 dissection. The his-
tological report confirmed the diagnosis of YST
and that two of the 14 regional lymph nodes
removed  were  metastatic.  Three  courses  of
PEB  regimen  chemotherapy  were  delivered
subsequently. Three months later the patient
experienced  dysphagia  from  stenosis  of  the
anastomosis and a computerized tomography
scan showed tumor recurrence with peritoneal
nodules; the patient died one year after sur-
gery. The origin of gastric YST is unclear but
involvement  of  migrating  germ  cells  during
embryonic development or multipotential neo-
plastic  protoepithelial  cells  of  the  gastric
mucosa  have  been  suggested.  Generally  the
prognosis of gastric YST is poor and the stan-
dard therapeutic approach beyond surgery is
still uncertain. 
Case Report
A 62-year-old man was admitted to our hos-
pital  with  a  medical  history  of  gastro-
esophageal  reflux  and  dyspepsia  lasting  for
three years, and a complaint a few days before
admission  of  gastric  pain  associated  with
severe asthenia. Weight loss and severe ane-
mia (6.5 g/dL) were also recorded.
Gastroscopy  examination  revealed  a  large
ulcerated tumor located in the antrum, where-
as  chest  and  abdominopelvic  computerized
tomography (CT) scans did not demonstrate
distant metastases. As a preoperative histolog-
ical  diagnosis  of  adenocarcinoma  was  ren-
dered on small tissue biopsies taken during
endoscopic evaluation, the patient underwent
total  gastrectomy  with  D2  dissection  and
omentectomy followed by digiunostomy.
The tumor, with a maximum diameter of 7
cm, was composed microscopically of neoplas-
tic cells with pale eosinophilic to water-clear
cytoplasm including some hyaline droplets and
with round to oval vesicular nuclei and variably
sized nucleoli. Tumor cells were arranged into
solid  and  papillary  or  pseudopapillary  struc-
tures (Figure 1 A and B) with several glomeru-
loid aggregates resembling Schiller-Duval bod-
ies (Figure 1B). These cells showed immuno-
reactivity for cytokeratins (Figure 1C) and α-
fetoprotein (Figure 1D) but not for chromo-
granin A, cytokeratins 7 and 20, β-HCG, CDX2,
placental  alkaline  phosphatase,  and  CD30.
Immunostains  for  CEA  and  EMA  were  com-
pletely negative as one would expect for a case
of pure gastric yolk sac tumor (YST). In order
to exclude foci of conventional gastric adeno-
carcinoma  or  another  germ  cell  tumor,  we
processed a paraffin block for every centimeter
of  gross  tumor  size,  cutting  and  examining
each block at three different levels: no other
components were found, which reinforced the
final diagnosis of YST. The surgical margins
were  free  of  disease  but  two  out  of  the  14
regional lymph nodes removed were metastat-
ic. All these morphological and immunohisto-
chemical  findings  were  consistent  with  the
diagnosis  of  YST.  Postoperatively  ʱ-fetopro-
tein  was  4.8  ng/mL  (normal  range:  0-10
ng/mL). A subsequent objective examination
of the patient did not reveal any lesion at tes-
ticular  sites.  The  patient  underwent
chemotherapy with three courses of PEB regi-
men  (cisplatin  100  mg/mq,  day  1;  etoposide
100 mg/mq, days 1-3; bleomycin 30 mg, days 2,
9, 16; but omitting bleomycin on days 2 and 9
after the first cycle). In addition, support with
granulocyte  stimulating  factor  was  needed
because  of  hematological  toxicity.  Three
months  after  the  end  of  chemotherapy  the
patient experienced dysphagia from stenosis
of the anastomosis and an abdominopelvic CT
scan showed tumor recurrence with peritoneal
nodules  and  ascites.  The  α-fetoprotein  was
>50 ng/mL. As the patient deteriorated rapidly
with systemic fever and abdominal pain, par-
enteral nutrition was started without adminis-
tering  further  antitumor  treatments.  Death
occurred one year after surgery. 
Discussion
Gastric YST may affect elderly patients, as
confirmed by our case, but clinical symptoms
are most often unspecific and related to organ
diffusion. Preoperatively ʱ-fetoprotein is also
a reliable tumor marker giving a well-defined
histological  feature  at  diagnosis.  The  first
choice of treatment of localized YST is surgical
resection despite a poor prognosis related to
rapid  diffuse  relapse,  and  no  conventional
adjuvant  or  metastatic  treatments  are  avail-
able. YSTs are germ cell tumors mostly found
in the gonads. Extragonadal sites are reported
in 20% of cases, occurring along the midline in
the  mediastinum,  in  the  retroperitoneum,
sacral area, and skull base. However, primary
pure YST of the stomach is exceptional, with
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Figure  1.  Histological
features of a gastric yolk
sac  tumor.  (A)  Tumor
cells,  with  pale  eosino-
philic  cytoplasm  and
vesicular  nuclei,  appear
to be arranged into solid
and  papillary  or
pseudopapillary  struc-
tures.  (B)  Several
glomeruloid  aggregates
of  the  neoplastic  cells
resembling  Schiller-
Duval bodies are evident.
The tumor cells showed
immunoreactivity  for
cytokeratins (C) and for
ʱ-fetoprotein (D).
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1-5 (Table 1). Gastric YST may also be accom-
panied by other neoplastic components includ-
ing  conventional  adenocarcinomas,  or  other
germ cell components such as choriocarcino-
mas and embryonal carcinomas.
6,7 To the best
of our knowledge, only six cases of pure YST of
the stomach, with a median age of 65 years
(range 36-87 yr), and five cases of YST com-
bined with adenocarcinoma
8 have been report-
ed. Generally high levels of α-fetoprotein are
detected in the serum of patients with gastric
YST. In our case this assay was performed only
after complete surgical resection and its value
was within the normal range.
The  origin  of  gastric  YST  is  unclear,  but
involvement  of  migrating  germ  cells  during
embryonic  development
9,10 or  multipotential
neoplastic protoepithelial cells of the gastric
mucosa
6 have  been  implicated.  In  combined
variants of YST with conventional adenocarci-
noma, α-fetoprotein was expressed strongly in
the YST but not in the adenocarcinoma compo-
nent, whereas the reverse held true for carci-
noembryonic antigen.
11 A common derivation
of combined tumors from a common ancestor
has been suggested on the basis of the differ-
ential  distribution  of  p53  nuclear  accumula-
tion in the YST and adenocarcinoma compo-
nents.
12
The  prognosis  of  gastric  YST  is  generally
poor  and  the  standard  therapeutic  approach
beyond surgery is still uncertain, with many
patients experiencing widespread metastases
at  the  time  of  diagnosis.  Overall  survival  of
published cases was one to seven months, with
the exception of one 72-year-old patient with-
out distant disease at diagnosis, who lived for
a further three years.
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